COc1cc([C@H]2c3cc4c(cc3[C@H](NCc3ccc([N+](=O)[O-])cc3)C3COC(=O)[C@H]32)OCO4)cc(OC)c1O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?